Using a panel of 13 CP‐sensitive or CP‐resistant ovarian cancer cell lines and five platinum‐resistant cell lines from prostate or bladder cancer (Table S1), we systematically screened how DIPH impacts the cytotoxic effect of CP. Here, CP is linked to urinary bladder carcinoma.